“The first batch of the vaccine will be released within two weeks.”
“The vaccination will be voluntary anyway. Some doctors already have immunity against the coronavirus, about 20 percent … they assume that they don’t need a vaccination, it’s up to them to decide for themselves.”
“While meeting Russian needs is a priority, the vaccine could also be exported abroad.”
“The vaccine certainly has some export potential and we will certainly offer it overseas, but domestic market needs are our priority.”
The vaccine, named Sputnik V, was jointly developed by the Gamaleya Research Institute and the Russian Defense Ministry.
The Russian ruble is not benefiting from the above comments and higher oil prices as USD / RUB is up 0.18% so far as it is on its way to test 73.50.
The news however, about the vaccine appear to increase the overall risk sentiment of the market.